Connect with us

Defective Products

Toyota Has More Safety Recalls




Toyota has issued two more recalls since the massive recall in October for a defect that increases the risk for an airbag explosion. These two new recalls impact owners of Prius, Corolla, Corolla Hybrid and C-HR models.

Models with Recalls

The first recall is for 2019 Prius models that may have an electrical short circuit. A faulty combination meter is to blame, and it could lead to the speedometer and odometer not working as well as the fuel gauge. The recall is for 3800 vehicles and comes because the issue violates safety regulations. It could also cause the driver to become distracted.

Toyota will take care of the issue at dealerships by checking the combination meter and replacing the circuit board if needed. There is no cost to the owner of the vehicle. Notices of the recall will be sent out in February 2020.

The second recall is for certain C-HR, Corolla and Corolla Hybrid models and impacts the rear seat belt. These vehicles have two types of components for locking the seat belt in place. One of the mechanisms may have not been assembled correctly, which could allow the person being restrained to move forward in a crash. The result is an increased risk for injury. Owners of these vehicles can take their models to a Toyota dealership where the technicians will do an inspection. If they find an issue, they will replace the assemblies at no charge to the owner. The notice for this recall will also be sent out in February 2020.

Anyone who has questions about the recall can contact Toyota directly at their customer experience center at 800-331-4331. They can also talk to their dealership.

These recalls come after a major recall for over 920,000 models where the airbag may explode. For this recall, the models impacted include the following:

  • 2003-2006 Tundra
  • 2011-2013 Sienna
  • 2003-2013 Corolla
  • 2009-2010 Corolla Matrix
  • 2004-2005 RAV4
  • 2002-2007 Sequoia
  • 2008-2012 Scion xB
  • 2010-2016 4Runner
  • 2007-2012 Yaris

It also impacted several Lexus models, including the IS-F, ES350, GX460, SC430, IS250, IS350, IS250C and IS350C. Toyota will resolve this issue by replacing the airbag inflator or assembly.

Dangers with Recall Alerts

The second recall notice involving the rear seat belt is an obvious issue with safety. If a person isn’t restrained properly, they are more likely to suffer serious injury. They can hit their head or injury other areas of their body.

The first issue is not quite as obvious as to why it’s a safety issue, but a distracted driver can be dangerous on the road. Even if they only look down for a few seconds, their risk for an accident becomes significantly higher.

According to the NHTSA, distracted driving which involves cell phone usage increased to eight percent in 2015. Fatalities for these crashes went up to 14 percent during the same year. Distracted driving means taking one’s eyes off the road for any reason and for any time, even a few seconds. More car manufacturers are developing technology to detect when a driver is distracted.


Defective Products

Defective EpiPens Increase Risk of Death




The US Food and Drug Administration announced that certain EpiPens may fail to work correctly for allergic reactions. This includes the Ep
iPen 0.3 mg and EpiPen Jr 0.15 mg and generic versions of the products.

EpiPen Malfunction

According to the FDA, the EpiPens may delay injection of the epinephrine being given for a severe allergic reaction. They may also activate too soon if the safety release is removed from the side. The correct way to remove the blue safety release is to pull it straight up with one hand while holding the pen with the other. If the person attempts to hold it and remove the release with the same hand, it may activate the medicine.

The blue safety release may already be partially raised on some of the EpiPens. This would allow the device to activate before it should, which means the person wouldn’t receive the medication for the reaction.

Another issue with the devices is that some may fail to slide out of the carrier. Other user errors could cause the EpiPens not to work correctly. The FDA recommended that patients review the instructions that come with the EpiPen periodically to ensure they know what to do in an emergency.

Pharmacists should inspect the EpiPens before they are distributed to the patient. If a patient has a device and they are having an issue with it, they can contact the manufacturer at 800-796-9526 for a replacement at no cost to them.

What EpiPens Do

EpiPens contain epinephrine, which is a medication designed to open the airways in the lungs and narrow blood vessels. It works by injection to take effect immediately.

The medication can stop wheezing, bring up severely low blood pressure and stop hives and itching as well as other symptoms of an allergic reaction. The reactions may be caused by an allergy to foods, drugs, insect bites or stings and even anaphylaxis caused by exercise. It can be given by the person suffering from the reaction and is generally kept on hand for anyone with a history of severe reactions to allergens.

The EpiPen Auto-Injector is designed for people who weigh at least 66 pounds. The EpiPen Jr Auto—Injector is prescribed for those who weight at least 33 pounds but no more than 66 pounds.

It’s important to contact a doctor after using the EpiPen even if the symptoms of the allergic reaction wear off. The EpiPen only lasts for about 30 minutes, and the person may start to have a reaction again.

Anyone who has an EpiPen should review the information and make sure they understand how it works. If they don’t, they can ask their pharmacist or doctor for information. They should also check the device to see if it is working correctly. If not, it should be replaced. It can be life-threatening to rely on the EpiPen when a person is having an episode and not have it work correctly or fail to dispense the medication at all.

Continue Reading

Defective Products

Health Concerns Over Vaping Limit Juul’s Expansion in Global Markets




In 2019, a mysterious lung illness was linked to vaping, and several people died while thousands were diagnosed and treated. JUUL, one of the manufacturers of vaping devices, has seen more restrictions in the US because of the situation. To continue to be successful, JUUL has looked at expanding globally where fewer restrictions make it easier for vaping devices to gain new users.

Going Global

JUUL has looked at moving into several global markets in the past year. Following the strategy employed by cigarette companies, JUUL saw potential to win new consumers around the world with its vaping devices, especially after flavored devices were banned in the US.

While the company began its plan for expansion, many of these plans have been thwarted. JUUL was removed from the China market just four days after entry. Other markets that have proven fruitless include Thailand, India, Singapore, Philippines, Laos and Cambodia. JUUL has also delayed a launch in the Netherlands and stopped sales in Israel.

It appeared that South Korea would be a legitimate market for the manufacturer with a third of the men smoking and many consumers interested in the latest in Western technology and goods. JUUL started out with fast growth in the country and soon became a top brand for vaping products.

Two issues plagued JUUL in this lucrative market. First, a tax on e-liquid products made vaping devices expensive. Second, the amount of nicotine allowed in these devices is just one percent, which is less than the three and five percent that had been allowed in JUUL’s products in the US. A warning from the South Korea government about damage to the lungs from vaping products add to the problems for the vaping manufacturer.

Vaping Illness Casts Black Cloud on JUUL

Even though JUUL products aren’t linked to the lung illness, it has had an adverse effect on the company’s ability to enter global markets. Sales dropped dramatically in South Korea as the entire vaping industry was hard hit with a reduction of 90 percent in sales in the fourth quarter of 2019.

While JUUL products began to be sold in India in 2018, an official launch was planned for late 2019. India banned all e-cigarettes in the country before the launch could happen. In Indonesia, JUUL became quite popular with the younger crowd. While JUUL tried to make its products appeal as devices to help smokers stop smoking, the real use for the product came from those who both smoked and vaped as well as those who had never smoked.

While JUUL pulled out of Indonesia, many people are concerned that sales will just move online. Experts say that it’s already a flourishing market.

The illnesses in the US that were linked to vaping has led to concern around the world. Many countries that before were quite lenient with vaping have now taken action to limit or even ban the products. JUUL’s strategy to expand around the world has been delayed at least if not completed altered.

Continue Reading

Defective Products

Vaping Could Increase Health Risk with COVID-19




The US Centers for Disease Control and Prevention has issued recommendations for those who are elderly and people who are high-risk for dealing with COVID-19. Another group who may be at risk for this disease is anyone who smokes or vapes.

Vaping Illnesses

Vaping has already been tied to a serious lung illness with many cases diagnosed and treated from the summer of 2019. Like the vaping illness, COVID-19 attacks the lungs, which could leave those who are smoking or vaping even more susceptible.

The illness tied to vaping results in permanent damage to the lungs. Many of patients have gone to the emergency room and even been put on ventilators to help with breathing because of the severity of the situation. Several have died from the disease. Those who vape may also suffer more serious effects of any illness, including flu. The issue becomes even more frightening with COVID-19.

When a person vapes, it impacts their lungs. The lungs have more difficulty clearing out foreign substances and working at normal capacity. Some experts are wondering if vaping has contributed to the number of younger people being hospitalized for the virus. A study done in China shows that people who smoke have a 14 times greater chance of developing a severe case of COVID-19 than someone who doesn’t. These same people have a 14 percent higher chance of getting pneumonia.

Along with people who smoke and vape, anyone abusing drugs could also be at an increased risk. Many of these drugs have a negative effect on the respiratory system. Opioids slow down the breathing rate, which makes it more difficult to get enough air and to send enough oxygen to the organs. Opioid misuse is already linked to an increased death rate in people who are diagnosed with respiratory issues. For many drug users, they double their risk because they also smoke or vape.

Fatalities with Vapers

With the vaping illness, many people went to the emergency room because they couldn’t breathe. The most serious cases would be put on a ventilator, and many died from the disease. The issues are similar with COVID-19. It can start with a cough and fever, but it can quickly lead to shortness of breath and pneumonia. Doctors are concerned with the need for ventilators for those who have underlying conditions or are at a higher risk. Thousands of people have already died from this virus, and vapers and smokers most likely will end up with a higher fatality rate if they are exposed.

While there were some similarities on cases involving the vaping-related lung disease, no single cause was found. Many experts and agencies recommended that people stop vaping or at least not buy vaping products from off the street because they might not know what ingredients were included. With the virus running rampant throughout the US, most experts would agree to stop vaping regardless of what products are being used.

The single best thing that anyone can do to avoid complications with the virus is to reduce their risk. That means stop smoking or vaping.

Continue Reading